Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01263743 · ClinicalTrials.gov registry record · NA
Relaxation Response Training to Treat Hypertension
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT01263743: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01263743 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01263743, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
Interventions such as Relaxation Response appear to have widespread effects on physiology. Endothelial function, changes in genomic expression, several biomarkers have been associated with chronic stress and cardiovascular dysfunction, and there is some suggestion that elicitation of the Relaxation Response may lead to improvement in-or normalization of-these factors. By studying the impact of the Relaxation Response on endothelial function, genomic expression and biomarkers among subjects with hypertension, it may be possible to better understand the biologic underpinnings of Relaxation Response-type interventions. Furthermore, with a greater understanding of the physiologic mechanisms by which the Relaxation Response works, it may be possible to better target other symptoms and conditions that can be effectively treated by such an intervention.
Interventions
- BEHAVIORAL Relaxation Response
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01263743
The ClinicalTrials.gov registry entry for NCT01263743 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relaxation Response is the first listed.
NCT01263743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01263743 about?
NCT01263743 is a clinical study titled "Relaxation Response Training to Treat Hypertension". Interventions such as Relaxation Response appear to have widespread effects on physiology. Endothelial function, changes in genomic expression, several biomarkers have been associated with chronic stress and cardiovascular dysfunction, and there is some suggestion that elicitation of the Relaxation ...
What is the current status of trial NCT01263743?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2009-04. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01263743?
The interventions under investigation include: Relaxation Response (BEHAVIORAL).
Who is sponsoring clinical trial NCT01263743?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.